Homonymous Hemianopia in Childhood (HHIC)

The study will consist of two connected components at a single centre. Phase 1 is observational, phenotyping children with Homonymous hemianopia (HH). Phase 2 is a pilot double blind cross over RCT in which segmental prisms are compared with sham prisms in glasses.

Study Overview

• Status: Enrolling by invitation
• Conditions: Homonymous Hemianopia
• Intervention / Treatment: Other: Sham; Other: Prism

Detailed Description

The project will consist of two connected pieces of work. The primary phase of the study will examine children with a diagnosis of homonymous hemianopia to investigate the clinical spectrum, and undertake questionnaires to measure vision related quality of life and visual function. Functional evaluation will also include optical coherence tomography, electrophysiological and eye movement studies.

If the recruited children or young people meet the inclusion criteria for phase two they will then be given the option of taking part in phase 2 - a pilot randomised cross-over trial of prism glasses. The order in which the prism lenses and the sham lenses are given will be randomised, with each worn for four weeks. The child or young person and their parent carer will be asked for their opinion on each pair, with the primary outcome question "If the trial was to end today would you want to continue wearing these lenses?" (Yes/no). Visual function will be measured behaviourally using a questionnaire based tool, and functionally utilising an eye movement recording of a visual search task.

The project consists of two connected studies. The primary phase of the study will examine children with homonymous hemianopia to investigate the spectrum of eye features. This will involve doing several different eye tests, similar to ones used in clinical practice. All children will have a photo of their eye taken that measures the thickness of the nerve at the back of the eye. They will also have electrodes put on their head and around their eyes that will measure the brains response to different visual stimuli. This is not painful and they children can choose a carton to watch during it to make it more entertaining. The children will also have their eye movements measured as they follow a target on a TV screen towards the non-seeing and seeing half of the vision. The children will also be asked to do some drawing tasks such as putting numbers on a clock face, or drawing a house to see how much they do or don't ignore the side with the visual impairment. They will also undertake age appropriate questionnaires to measure their vision related quality of life and visual function. This will give us more information about what impact the HH has on different aspects of their lives.

If the recruited children in phase 1 meet the inclusion criteria for phase 2 they will be invited to take part. Phase 2 is a trial of prisms glasses. Participants will be told they are trialing two different pairs of glasses one with the full prism and one with a weaker (sham) prism, and will be unaware which one is which, as will the study investigator. The order in which they wear the glasses will be random. They will wear each pair for four weeks and return for an assessment at the end of each four weeks of wear. At each assessment the children will complete a questionnaire to measure if or how the glasses helped them.

They will also have their eye movements measured to see if they make more compensatory movements towards the blind side. Patient's opinions will also be recorded including responses to the question "If the trial was to end today would you want to continue wearing these glasses?".

• Study Type: Interventional
• Enrollment (Estimated): 25
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • London, United Kingdom
    • Great Ormond Street Hospital for Chidlren

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

Phase 1 inclusion criteria:

1. Clinical diagnosis of homonymous hemianopia
2. Age 5 to 17
3. Corrected visual acuity within normal limits for age,
4. No evidence of eye pathology (pathology of the eye its self that causes additional visual impairment on top of the homonymous hemianopia) including no nystagmus
5. No marked refractive error > +/-5.00DS
6. Complete homonymous hemianopia of more than 6 months - to avoid any natural recovery or adaptation (i.e. in stroke)

Phase 2 inclusion criteria:

1. Participation in phase 1 or copy of a detailed clinical assessment in the last 6 months from GOSH or a PIC site.
2. No hemispatial visual neglect detected in phase one or a clinical assessment
3. Aged 7 to 17
4. Corrected visual acuity within normal limits for age,
5. No evidence of eye pathology (pathology of the eye its self that causes additional visual impairment on top of the homonymous hemianopia) including no nystagmus
6. No marked refractive error > +/-5.00DS
7. Complete homonymous hemianopia of more than 6 months - to avoid any natural recovery or adaptation (i.e. in stroke)

Exclusion Criteria:

Phase 1 exclusion criteria:

1. Cannot establish definite clinical diagnosis of homonymous hemianopia
2. Have participated in other studies undertaking intervention for homonymous hemianopia
3. Reduced corrected visual acuity for age and/or high glasses prescription.
4. Eye pathology (that causes additional visual impairment to the homonymous hemianopia) and/or nystagmus
5. Homonymous hemianopia incomplete or less than 6 months old
6. Suspected or proven deficit of the unaffected hemisphere of the brain

Phase 2 exclusion criteria:

1. No participation in phase 1 or copy of a detailed ophthalmology assessment in the last 6 months from GOSH or a PIC site.
2. Hemispatial visual neglect
3. Cannot establish definite clinical diagnosis of homonymous hemianopia
4. Age/ability/additional disability means cannot give subjective responses
5. Have participated in other studies doing intervention for homonymous hemianopia
6. Reduced corrected visual acuity for age and/or high glasses prescription
7. Eye pathology (that causes additional visual impairment to the homonymous hemianopia) and/or nystagmus
8. Homonymous hemianopia incomplete or less than 6 months old
9. Suspected or proven deficit of the unaffected hemisphere of the brain

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: Triple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Prism followed by sham	Other: Sham; Sham; Other: Prism; Prism
Other: Sham followed by prism	Other: Sham; Sham; Other: Prism; Prism

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Is it possible to run a full randomised control trial of the use of segmental prisms in children with Homonymous Hemianopia?	My primary outcome is asking participants "if the trial ended would you want to continue wearing these glasses?"	2 years

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Is it possible to run a full randomised control trial of the use of segmental prisms in children with Homonymous Hemianopia?	Recruitment rates using descriptive statistics.	2 years
Is it possible to run a full randomised control trial of the use of segmental prisms in children with Homonymous Hemianopia?	Retention rate using descriptive statistics.	2 years
Is it possible to run a full randomised control trial of the use of segmental prisms in children with Homonymous Hemianopia?	Reporting any harms or unintended effects (descriptive statistics).	2 years

Collaborators and Investigators

• Sponsor: Institute of Child Health
• Investigators: Principal Investigator: Jugnoo Rahi, GOSH Institute of Child Health

Study record dates

Study Major Dates

• Study Start (Actual): May 4, 2023
• Primary Completion (Estimated): March 31, 2024
• Study Completion (Estimated): July 1, 2025

Study Registration Dates

• First Submitted: August 30, 2023
• First Submitted That Met QC Criteria: October 31, 2023
• First Posted (Estimated): November 3, 2023

Study Record Updates

• Last Update Posted (Estimated): November 3, 2023
• Last Update Submitted That Met QC Criteria: October 31, 2023
• Last Verified: October 1, 2023

More Information

Terms related to this study

• Keywords: Homonymous Hemianopia; Children and Young People
• Additional Relevant MeSH Terms: Nervous System Diseases; Eye Diseases; Neurologic Manifestations; Sensation Disorders; Vision Disorders; Blindness; Hemianopsia
• Other Study ID Numbers: 18BA25

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No